» Articles » PMID: 32665600

Exploring the Wound Healing, Anti-inflammatory, Anti-pathogenic and Proteomic Effects of Lactic Acid Bacteria on Keratinocytes

Abstract

The topical application of lactic acid bacteria (LAB) is recognized as a useful approach to improve skin health. This work aims to characterize by a multidisciplinary approach, the wound healing, anti-inflammatory, anti-pathogens and proteomic effects of six LAB lysates, belonging to the genus Lactobacillus. Our results demonstrated that the lysates of tested LAB stimulated the proliferation of keratinocytes, and that L. plantarum SGL 07 and L. salivarius SGL 19 accelerated the re-epithelization by inducing keratinocyte migration. The bacterial lysates also reduced the secretion of specific pro-inflammatory mediators from keratinocytes. Furthermore, viable L. salivarius SGL 19 and L. fermentum SGL 10 had anti-pathogenic effects against S. aureus and S. pyogenes, while L. brevis SGL 12 and L. paracasei SGL 04 inhibited S. aureus and S. pyogenes, respectively. The tested lactobacilli lysates also induced specific proteome modulation of the exposed keratinocytes, involving dysregulation of proteins (such as interleukin enhancer-binding factor 2 and ATP-dependent RNA helicase) and pathways (such as cytokine, NF-kB, Hedgehog, and RUNX signaling) associated with their specific wound healing and anti-inflammatory effects. This study indicates the different potential of selected lactobacilli, suggesting that they may be successfully used in the future together with conventional therapies to bring relief from skin disorders.

Citing Articles

Lactobacillus lysates protect oral epithelial cells from pathogen-associated damage, increase secretion of pro-inflammatory cytokines and enhance barrier integrity.

Mercer S, Doherty C, Singh G, Willmott T, Cheesapcharoen T, Teanpaisan R Sci Rep. 2025; 15(1):5894.

PMID: 39966408 PMC: 11836205. DOI: 10.1038/s41598-025-86914-y.


UBLP-40 Versus the Combined Formula of UBLP-58 and UBBL-64 in Excisional Wound Healing: A Cellular Perspective.

Moysidis M, Chorti A, Cheva A, Abba Deka I, Tzikos G, Kosmidis C Pharmaceuticals (Basel). 2024; 17(11).

PMID: 39598326 PMC: 11597307. DOI: 10.3390/ph17111414.


Probiotic-Derived P8 Protein: Promoting Proliferation and Migration in Stem Cells and Keratinocytes.

Jang S, Kim Y, Yeo H, Yeo H, Kang G, An B Int J Stem Cells. 2024; 18(1):87-98.

PMID: 39491493 PMC: 11867908. DOI: 10.15283/ijsc24107.


Exploring Deep Eutectic Solvents as Pharmaceutical Excipients: Enhancing the Solubility of Ibuprofen and Mefenamic Acid.

Nica M, Anuta V, Nicolae C, Popa L, Ghica M, Cocos F Pharmaceuticals (Basel). 2024; 17(10).

PMID: 39458957 PMC: 11510164. DOI: 10.3390/ph17101316.


Global Trends and Scientific Impact of Topical Probiotics in Dermatological Treatment and Skincare.

Alves A, Martins Jr S, Belo J, Lemos M, de Matos Chaves Lima C, Silva C Microorganisms. 2024; 12(10).

PMID: 39458319 PMC: 11510400. DOI: 10.3390/microorganisms12102010.


References
1.
Egert M, Simmering R, Riedel C . The Association of the Skin Microbiota With Health, Immunity, and Disease. Clin Pharmacol Ther. 2017; 102(1):62-69. DOI: 10.1002/cpt.698. View

2.
Roudsari M, Karimi R, Sohrabvandi S, Mortazavian A . Health effects of probiotics on the skin. Crit Rev Food Sci Nutr. 2013; 55(9):1219-40. DOI: 10.1080/10408398.2012.680078. View

3.
Knackstedt R, Knackstedt T, Gatherwright J . The role of topical probiotics in skin conditions: A systematic review of animal and human studies and implications for future therapies. Exp Dermatol. 2019; 29(1):15-21. DOI: 10.1111/exd.14032. View

4.
Baquerizo Nole K, Yim E, Keri J . Probiotics and prebiotics in dermatology. J Am Acad Dermatol. 2014; 71(4):814-21. DOI: 10.1016/j.jaad.2014.04.050. View

5.
Al-Ghazzewi F, Tester R . Impact of prebiotics and probiotics on skin health. Benef Microbes. 2014; 5(2):99-107. DOI: 10.3920/BM2013.0040. View